

<HTML>
<HEAD>

<link rel="stylesheet" href="/v3.css" type="text/css">










<TITLE>NEJM -- Case 30-2004 - A 37-Year-Old Woman with Paresthesias of the Arms and Legs</TITLE>
<meta name="description" content="Case Records of the Massachusetts General Hospital from The New England Journal of Medicine -- Case 30-2004 - A 37-Year-Old Woman with Paresthesias of the Arms and Legs">

<meta name="robots" content="nofollow">




<script type="text/javascript" src="/misc/folders.js"></script>
</HEAD>


  

























	




















<!-- start PPT check-->


<!-- end PPT check-->









 
 
  







<body bgcolor="#FFFFFF" link="#FF3300" vlink="#666699" text="#000000" alink="#FF3300">

<!-- BEGIN: Use this section to set page specific variables for the NetTracker Page Tag -->
<script language="JavaScript">
// var NTPT_PGEXTRA = '';
// var NTPT_PGREFTOP = false;
// var NTPT_NOINITIALTAG = false;
</script>
<!-- END: Use this section to set page specific variables for the NetTracker Page Tag -->
<!-- BEGIN: NetTracker Page Tag -->
<!-- Copyright 2004 Sane Solutions, LLC. All rights reserved. -->
<script language="JavaScript" src="/ntpagetag.js"></script>
<noscript>
<img src="/icons/ntpagetag.gif?js=0" height="1" width="1" border="0" hspace="0" vspace="0" alt="">
</noscript>
<!-- END: NetTracker Page Tag -->







<!-- No CheckM8 category -->




<A NAME="top"><!-- null --></A>

	<table width="100%" border="0" cellspacing="0" cellpadding="0" align="center">
	
	
	<tr align="center"> 
	<td bgcolor="#FF3300"><img src="/icons/spacer.gif" width="1" height="3" alt=""></td>
	</tr>
	
	<tr align="center"> 
	<td><a href="/"><img src="/icons/banner/v2_title_large.gif" border="0" alt="The New England Journal of Medicine" width="482" height="95"></a></td>
	</tr>
	
	<tr> 
	<td valign="top" align="center" bgcolor="#E8E8D1"><img src="/icons/spacer.gif" width="100%" height="5" alt=""></td>
	</tr>
	
	<tr> 
	<td valign="top" align="center" bgcolor="#E8E8D1"><font face="arial, helvetica, sans-serif">
<a href="/" class="navBarLinks">HOME</a>
&nbsp;&nbsp;|&nbsp;&nbsp; <a href="/search.dtl" class="navBarLinks">SEARCH</a>
&nbsp;&nbsp;|&nbsp;&nbsp; <a href="/current.shtml" class="navBarLinks">CURRENT ISSUE</a>
&nbsp;&nbsp;|&nbsp;&nbsp; <a href="/contents-by-date.0.shtml" class="navBarLinks">PAST ISSUES</a>
&nbsp;&nbsp;|&nbsp;&nbsp; <a href="/collections/" class="navBarLinks">COLLECTIONS</a>
&nbsp;&nbsp;|&nbsp;&nbsp; <a href="/help/" class="navBarLinks">HELP</a>
</font></td>
	</tr>
	
	<tr> 
	<td valign="top" align="center" bgcolor="#E8E8D1"><img src="/icons/spacer.gif" width="100%" height="5" alt=""></td>
	</tr>
	
	<tr> 
	<td valign="top" align="center" bgcolor="#FF3300"><img src="/icons/spacer.gif" width="1" height="3" alt=""></td>
	</tr>
	
	<tr> 
	<td><img src="/icons/spacer.gif" width="100%" height="1" alt=""></td>
	</tr>
	
	<tr> 
	<td><font face="arial, helvetica, sans-serif" size="-2"><!-- subline logic: standard default -->







	
	

	





	
	
	
	 

	


	
	




				<FONT SIZE=-2>




				<NOBR><STRONG>Institution: BRANDEIS UNIV</STRONG></NOBR>

				
	   				
					
				
				| <NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F351%2F13%2F1333">Sign In as Individual</A></NOBR>
				|
				<NOBR><A TARGET="_top" HREF="mailto:keen@brandeis.edu">Contact Subscription Administrator at Your Institution</A></NOBR>
				
				 | <NOBR><STRONG><A TARGET="_top" HREF="http://www.nejm.org/Institute/faq.asp">FAQ</A></STRONG></NOBR>

				</FONT>
			

 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	


</font></td>
	</tr>
	
		
		<tr>
		<td>&nbsp;</td>
		</tr>
	
	
	</table>
	
	
<!-- include file -->
<!-- (do not remove) -->




         
                
        






<CENTER>
<table width="640" border="0" cellspacing="0" cellpadding="0">
	<TR VALIGN="TOP"> 
		<TD> 
			
								
				
				<DIV ALIGN="CENTER">
	<IMG VSPACE="7" SRC="/icons/content/v2_case_rec_head.gif" ALT="Case Records of the Massachusetts General Hospital">
	  
	  
	    <BR><IMG SRC="/icons/content/series/case_weekly_ednames_010604.gif" ALT="Editor's Names">
	  
	

	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	

				
          		<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="640">
				<TR>
					<TD VALIGN="TOP" NOWRAP><A HREF="/cgi/content/short/351/13/1332?query=prevarrow"><IMG ALT="Previous" WIDTH="9" HEIGHT="8" HSPACE="4" BORDER="0" SRC="/icons/v2_toc_arrowprev.gif"><FONT SIZE="-1" FACE="arial,helvetica">Previous</FONT></A></TD>
          			<TD ALIGN="CENTER" VALIGN="TOP"><TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
						<TH ALIGN="RIGHT" VALIGN="TOP" NOWRAP>Volume 351:1333-1341</TH>
						<TD NOWRAP><IMG ALT="" WIDTH="30" HEIGHT="30" SRC="/icons/spacer.gif"></TD>
						<TH VALIGN="TOP" NOWRAP><A HREF="/content/vol351/issue13/index.shtml"><FONT COLOR="#000000">September 23, 2004</FONT></A></TH>
						<TD NOWRAP><IMG ALT="" WIDTH="30" HEIGHT="30" SRC="/icons/spacer.gif"></TD>
						<TH ALIGN="LEFT" VALIGN="TOP" NOWRAP>Number 13</TH>
					</TR></TABLE></TD>
					<TD VALIGN="TOP" ALIGN="RIGHT" NOWRAP><A HREF="/cgi/content/short/351/13/1343?query=nextarrow"><FONT SIZE="-1" FACE="arial,helvetica">Next</FONT><IMG ALT="Next" WIDTH="9" HEIGHT="8" HSPACE="4" BORDER="0" SRC="/icons/v2_toc_arrownext.gif"></A></TD>
          		</TR>
				</TABLE>
				
          		</DIV>
      			
      		

      </TD>
    </TR>
</TABLE>
</CENTER>
<P>





<div align="center"><b><FONT SIZE="+2" face="Arial, Helvetica, sans-serif">Case 30-2004 &#151; A 37-Year-Old Woman with Paresthesias of the Arms and Legs</FONT></B><BR></div>


	
	<CENTER><FONT SIZE="+1"><I>
	
	
			Peter W. Marks, M.D., Ph.D., and Lawrence R. Zukerberg, M.D.
		
	</I></FONT></CENTER>







<P>

 



 
		                    



 
	 

<table border="0" cellpadding="0" cellspacing="0" width="200" ALIGN="RIGHT">
<tr>
<td width="20">&nbsp;</td>
<TD BGCOLOR="336699">

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1">

	<TR VALIGN="top">
		<td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
			<img src="/icons/v3_this_article.gif" alt="This Article" width="73" height="8" BORDER="0"><BR>
			<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
	</tr><tr>
		<td> 
                <table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
		<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
		
		
		
		

		
		 

		
		<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b>
			
			
			
				
						
						<A class="contentboxLinks" HREF="/cgi/reprint/351/13/1333.pdf">PDF</A></b></font></td></tr>
		
		<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/ac_external_ref?link_type=pda_mms&doi=10.1056%2FNEJMcpc040921">PDA Full Text</A></b></font></td></tr>
		
		
			<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="http://cme.nejm.org/cgi/cme/nejmcme_course;NJ200409233511334">CME Exam</A></b></font></td></tr>
		
		

		

		

		 
		
		



	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	</table>
        </td>
        </tr>







        <tr>
        <td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
	<img src="/icons/v3_commentary.gif" alt="Commentary" width="80" height="8" align="absmiddle"><BR>
	<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
        </tr>
        <tr>
        <td>
        <table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
        
	
	
	
	
	
	
		<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="#related_letters">Letters</A></b></font></td></tr>
	
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	</table>
	</td>
	</tr>



	<tr> 
	<td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
	<img src="/icons/v3_tools_service.gif" alt="Tools and Services" width="103" height="9" align="absmiddle"><BR>
	<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
	</tr>
	<tr> 
	<td> 
	<table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	
		
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/folders?action=addtofolder&wherefrom=JOURNALS&wrapped_id=nejm;351/13/1333">Add to Personal Archive</A></b></font></td></tr>
	
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/citmgr?gca=nejm;351/13/1333">Add to Citation Manager</A></b></font></td></tr>
	
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/mailafriend?url=http://content.nejm.org/cgi/content/short/351/13/1333&title=Case+30-2004+-+A+37-Year-Old+Woman+with+Paresthesias+of+the+Arms+and+Legs"><b>Notify a Friend</b></a></b></font></td></tr>

	
        <tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=nejm;351/13/1333&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F351%2F13%2F1333">E-mail When Cited</A></b></font></td></tr>

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/ac_external_ref?link_type=letters_mms&doi=10.1056%2FNEJMcpc040921">E-mail When Letters Appear</A></b></font></td></tr>
	
	
	
	

	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	</table>
        </td>
        </tr>



        <tr>
        <td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
	<img src="/icons/v3_more_information.gif" alt="More Information" width="116" height="8" align="absmiddle"><BR>
	<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
        </tr>
        <tr>
        <td>
        <table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
        

	

	

	

	

	

	

	

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/search?qbe=nejm;351/13/1333&journalcode=nejm&minscore=5000">Find Similar Articles</A></b></font></td></tr>

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/external_ref?access_num=15385661&link_type=PUBMED" onClick="ISIwin('ISI')" TARGET="ISI">PubMed Citation</A></b></font></td></tr>

<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
</table>
</td>
</tr>

        
        
</table>
</table>	 <!-- end of outer content box1 -->
</TABLE>	 <!-- end of outer content box2 -->










 





	
	
	
	
	
	
	
	
	
		


<!-- <CENTER><H2><FONT FACE="arial, helvetica">
Case 30-2004
</FONT></H2> </CENTER> -->
<!-- <H3>
A 37-Year-Old Woman with Paresthesias of the Arms and Legs
</H3> -->


<!--<CENTER><I>
</NOBR><NOBR>Peter W. Marks, M.D., Ph.D.</NOBR> and 
<NOBR>Lawrence R. Zukerberg, M.D.</NOBR>
</I></CENTER><P>
-->


<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Presentation of Case</STRONG></FONT><P>

A 37-year-old woman was seen in the clinic because of numbness<SUP> </SUP>in the arms and legs.<SUP> </SUP><P>

Four months earlier, she had noticed tingling and numbness in<SUP> </SUP>the fingertips, without weakness, three weeks after having last<SUP> </SUP>ridden a bicycle. She consulted her primary care physician.<SUP> </SUP>The temperature was 37.2&#176;C and the blood pressure 115/85<SUP> </SUP>mm Hg. The height was 1.75 m and the weight 69.1 kg. The lungs<SUP> </SUP>were clear to auscultation, and the heart sounds were normal.<SUP> </SUP>No rash or lymphadenopathy was found. Examination of the breasts,<SUP> </SUP>abdomen, and arms and legs and a pelvic examination revealed<SUP> </SUP>no abnormalities. The range of motion of the neck and the hand-grip<SUP> </SUP>strength were normal; the sensation in the hands also seemed<SUP> </SUP>to be intact. No treatment was given, and the symptoms resolved<SUP> </SUP>after three weeks.<SUP> </SUP><P>

Two and a half months later she noticed fresh blood on the toilet<SUP> </SUP>tissue after passing a stool. Rectal examination revealed a<SUP> </SUP>hemorrhoid. Shortly thereafter she had a brief illness, characterized<SUP> </SUP>by nausea, possible fever, and leg fatigue on exertion. During<SUP> </SUP>the next several weeks, she noticed the onset of numbness and<SUP> </SUP>tingling that extended from the fingertips to the upper arms;<SUP> </SUP>subsequently, numbness and tingling developed in the legs as<SUP> </SUP>well. She also noticed weakness in her legs, to the extent that<SUP> </SUP>she could no longer run a mile and was losing her balance. She<SUP> </SUP>recalled seeing apparent insect bites on her lower legs after<SUP> </SUP>riding a bicycle in tall grass in the spring, in the suburban<SUP> </SUP>areas west of Boston. She had not recently traveled outside<SUP> </SUP>the Boston area. A review of her diet revealed that she ate<SUP> </SUP>meat and dairy products as well as vegetables and grains. She<SUP> </SUP>was referred to a neurologist.<SUP> </SUP><P>

Hypothyroidism had been discovered when the patient was 15 years<SUP> </SUP>old, and more recently depression had developed. A physical<SUP> </SUP>examination four months before the first episode of numbness<SUP> </SUP>and tingling had revealed no abnormalities. At that time, the<SUP> </SUP>levels of glucose, urea nitrogen, creatinine, calcium, total<SUP> </SUP>bilirubin, total protein, albumin, globulin, electrolytes, aspartate<SUP> </SUP>aminotransferase, alanine aminotransferase, and alkaline phosphatase<SUP> </SUP>were normal. Tests for IgG antibodies to herpes simplex virus<SUP> </SUP>types 1 and 2 were positive; tests for IgM antibodies and antibodies<SUP> </SUP>to hepatitis A virus were negative. Other laboratory-test results<SUP> </SUP>obtained at the time of that examination are shown in <A HREF="#T1">Table 1</A><SUP> </SUP>and <A HREF="#T2">Table 2</A>. She took levothyroxine (200 &#181;g) and sertraline<SUP> </SUP>(100 mg) daily. She was not married, and she worked in an office.<SUP> </SUP>She did not smoke or drink alcohol. She exercised regularly<SUP> </SUP>by running and riding a bicycle. Menarche had occurred when<SUP> </SUP>she was 14 years old, and she had regular menses. Her mother<SUP> </SUP>had had a coronary angioplasty, her father had lung and prostate<SUP> </SUP>cancer, a brother had asthma, and a paternal aunt had anemia<SUP> </SUP>of unknown nature.<SUP> </SUP><P>

<A NAME="T1"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/351/13/1333/T1">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/351/13/1333/T1"
    onClick="startTarget('T1', 730, 825); this.href='/cgi/content-nw/full/351/13/1333/T1'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T1">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Table 1.</B> Hematologic Laboratory Values.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


<A NAME="T2"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/351/13/1333/T2">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/351/13/1333/T2"
    onClick="startTarget('T2', 729, 548); this.href='/cgi/content-nw/full/351/13/1333/T2'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T2">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Table 2.</B> Blood Chemical Values.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


At the time of the patient's first visit to the neurologist,<SUP> </SUP>four months after the initial onset of tingling and numbness,<SUP> </SUP>the blood pressure was 110/80 mm Hg, and the weight 68.8 kg.<SUP> </SUP>She appeared well. Her mental status was normal, as were her<SUP> </SUP>cranial-nerve and motor functions. There was a slight delay<SUP> </SUP>in the relaxation of the deep-tendon reflexes; the plantar responses<SUP> </SUP>were flexor. Vibratory sensation was reduced in the feet, as<SUP> </SUP>was proprioception; other sensory responses were intact. The<SUP> </SUP>result of Romberg's test was normal. Cortical sensation (including<SUP> </SUP>graphesthesia, stereognosis, and tactile extinction) was normal.<SUP> </SUP><P>

Radiographs of the lumbar spine revealed no abnormalities. Cranial<SUP> </SUP>and cervical magnetic resonance imaging (MRI) and magnetic resonance<SUP> </SUP>angiographic studies, performed after the administration of<SUP> </SUP>gadolinium, disclosed no intracranial abnormalities. On T<SUB>2</SUB>-weighted<SUP> </SUP>images, there was apparent hyperintensity of the cervical spinal<SUP> </SUP>cord at the C2-to-C3 level, but at that level, the cord was<SUP> </SUP>incompletely evaluated. A subsequent, dedicated MRI study of<SUP> </SUP>the cervical spine revealed no abnormalities. Laboratory values<SUP> </SUP>obtained at the time of this visit are shown in <A HREF="#T1">Table 1</A> and<SUP> </SUP><A HREF="#T2">Table 2</A>.<SUP> </SUP><P>

A diagnostic procedure was performed.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Differential Diagnosis</STRONG></FONT><P>

<I>Dr. Peter W. Marks:</I> This young woman, who had a history of hypothyroidism,<SUP> </SUP>had a gradual onset of paresthesias of the hands and arms, followed<SUP> </SUP>by paresthesias of the legs, and weakness that affected her<SUP> </SUP>ability to exercise. Although I am aware of the diagnosis in<SUP> </SUP>this case, it provides an opportunity to review the differential<SUP> </SUP>diagnosis of rather nonspecific initial symptoms.<SUP> </SUP><P>

<STRONG>Paresthesias</STRONG><P>

The term "paresthesia" is used to describe an abnormal burning<SUP> </SUP>or prickling sensation. It is often described by patients as<SUP> </SUP>numbness or tingling in a part of the body. Inadvertent compression<SUP> </SUP>of a nerve by pressure on an arm or leg may cause the transient<SUP> </SUP>paresthesia with which most of us are familiar. However, many<SUP> </SUP>diseases may be characterized by paresthesia as one of their<SUP> </SUP>initial features (<A HREF="#T3">Table 3</A>).<SUP> </SUP><P>

<A NAME="T3"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/351/13/1333/T3">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/351/13/1333/T3"
    onClick="startTarget('T3', 592, 1034); this.href='/cgi/content-nw/full/351/13/1333/T3'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T3">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Table 3.</B> Possible Causes of Paresthesias.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


Entrapment neuropathies, such as carpal tunnel syndrome, are<SUP> </SUP>relatively common. At the time of the patient's initial presentation,<SUP> </SUP>when she had paresthesias in the fingers after cycling, carpal<SUP> </SUP>tunnel syndrome may have been given serious consideration.<A HREF="#R1"><SUP>1</SUP></A><SUP> </SUP>However, the subsequent development of paresthesias in both<SUP> </SUP>the upper and lower limbs indicates the presence of a systemic<SUP> </SUP>disorder. Patients with central nervous system disorders may<SUP> </SUP>present with paresthesias, and in a young woman, multiple sclerosis<SUP> </SUP>is a concern. However, this patient's MRI examination revealed<SUP> </SUP>no abnormalities. No aspect of her history implicated agents<SUP> </SUP>such as alcohol, drugs, or other toxins. Many rheumatologic<SUP> </SUP>disorders can cause paresthesias, either through central nervous<SUP> </SUP>system effects, as in systemic lupus erythematosus, or through<SUP> </SUP>vasculitis that affects the peripheral nerves. Cancers may result<SUP> </SUP>in nerve compression, may invade or infiltrate the nerves, or<SUP> </SUP>may be associated with paraneoplastic phenomena. However, this<SUP> </SUP>patient does not have other signs or symptoms suggesting that<SUP> </SUP>she has a rheumatologic disease or cancer.<SUP> </SUP><P>

Infectious causes of paresthesia include Lyme disease, which<SUP> </SUP>is endemic in several areas of the United States. The presumed<SUP> </SUP>insect bites on the patient's legs raise the possibility of<SUP> </SUP>a vector-borne disease. Metabolic disorders such as diabetes<SUP> </SUP>mellitus, hypothyroidism, porphyria, uremia, and vitamin B<SUB>12</SUB><SUP> </SUP>deficiency can cause paresthesias through damage to central<SUP> </SUP>or peripheral nervous system structures. The patient had a history<SUP> </SUP>of hypothyroidism, but her thyrotropin level was normal at the<SUP> </SUP>time of the most recent measurement, although previously it<SUP> </SUP>had been abnormally elevated. Vitamin B<SUB>12</SUB> (cobalamin) deficiency<SUP> </SUP>may cause symmetric paresthesias and disorders of proprioception<SUP> </SUP>and vibratory sensation affecting the upper and lower limbs,<SUP> </SUP>even in the absence of overt anemia; this patient may have been<SUP> </SUP>at increased risk for this disorder, given her history of hypothyroidism.<SUP> </SUP>Though categorized as metabolic causes of paresthesias, both<SUP> </SUP>hypothyroidism and vitamin B<SUB>12</SUB> deficiency may be caused by autoimmune<SUP> </SUP>processes. Thus, in broad terms, the most likely causes of paresthesia<SUP> </SUP>in this patient are infectious or metabolic.<SUP> </SUP><P>

<STRONG>Macrocytic Anemia</STRONG><P>

At the time the patient visited the neurologist because of her<SUP> </SUP>symptoms, a complete blood count revealed macrocytic anemia.<SUP> </SUP>Macrocytic anemias have a number of causes and may be categorized<SUP> </SUP>as megaloblastic or nonmegaloblastic (<A HREF="#T4">Table 4</A>). Megaloblastic<SUP> </SUP>anemias, which result from defects in DNA synthesis and cell<SUP> </SUP>maturation, include anemias due to folate or vitamin B<SUB>12</SUB> deficiency,<SUP> </SUP>chemotherapeutic agents, or myelodysplasia. Although the patient<SUP> </SUP>subsequently had an episode of rectal bleeding from a hemorrhoid,<SUP> </SUP>she did not appear to be losing blood rapidly, so a brisk reticulocyte<SUP> </SUP>response is unlikely to be the cause of the macrocytosis. Although<SUP> </SUP>myelodysplasia would be unusual in a 37-year-old woman, it may<SUP> </SUP>occur at this age. <A NAME="1">The patient was not taking any medication<SUP> </SUP>that could cause a macrocytic anemia, such as zidovudine or<SUP> </SUP>a folate antagonist such as methotrexate.</A> She did not use alcohol<SUP> </SUP>and did not appear to have overt signs of liver disease. <A NAME="2">Although<SUP> </SUP>hypothyroidism may also cause macrocytic anemia, the increase<SUP> </SUP>in mean corpuscular volume in this condition is generally limited.</A><SUP> </SUP><A NAME="3">Folate or vitamin B<SUB>12</SUB> deficiency, on the other hand, may be<SUP> </SUP>associated with a substantial increase in the size of red cells.</A><SUP> </SUP>The mean corpuscular volume in this patient &#151; 114 &#181;m<SUP>3</SUP><SUP> </SUP>&#151; would be consistent with such a deficiency.<SUP> </SUP><P>

<A NAME="T4"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/351/13/1333/T4">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/351/13/1333/T4"
    onClick="startTarget('T4', 591, 608); this.href='/cgi/content-nw/full/351/13/1333/T4'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T4">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Table 4.</B> Possible Causes of Macrocytic Anemia.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


In this case, the correct diagnosis is suggested by the intersection<SUP> </SUP>of causes of paresthesia and causes of marked macrocytosis:<SUP> </SUP>vitamin B<SUB>12</SUB> (cobalamin) deficiency. Since this patient reported<SUP> </SUP>eating a diet containing some meat and dairy products, malabsorption<SUP> </SUP>of vitamin B<SUB>12</SUB> seems more likely than poor intake. In the absence<SUP> </SUP>of a history of gastrointestinal surgery or achlorhydria, the<SUP> </SUP>most likely cause of this patient's inability to absorb vitamin<SUP> </SUP>B<SUB>12</SUB> is pernicious anemia. This disorder would explain the patient's<SUP> </SUP>progressive paresthesias as well as her other neurologic findings.<SUP> </SUP>Although the prevalence of pernicious anemia increases with<SUP> </SUP>advancing age, it may occur in young persons, particularly if<SUP> </SUP>it is a manifestation of a heritable syndrome.<SUP> </SUP><P>

<STRONG>Autoimmune Polyendocrine Syndrome</STRONG><P>

<A NAME="4">Pernicious anemia is an autoimmune disorder.<A HREF="#R2"><SUP>2</SUP></A></A> In this patient,<SUP> </SUP>in whom hypothyroidism and probable pernicious anemia had developed<SUP> </SUP>at an early age and who had a family history of anemia, we must<SUP> </SUP>consider one of the syndromes of polyglandular failure. At least<SUP> </SUP>three major constellations of findings have been identified;<SUP> </SUP>they are termed autoimmune polyendocrine syndrome types I, II,<SUP> </SUP>and III (<A HREF="#T5">Table 5</A>).<A HREF="#R3"><SUP>3</SUP></A> In type III disease, autoimmune thyroiditis<SUP> </SUP>is associated with another organ-specific autoimmune disease.<SUP> </SUP>Three subcategories of type III disease have been described,<SUP> </SUP>according to the disorder associated with the autoimmune thyroiditis.<SUP> </SUP>One of these, type IIIB, which consists of autoimmune thyroiditis<SUP> </SUP>and pernicious anemia, is consistent with this patient's characteristics<SUP> </SUP>on presentation.<SUP> </SUP><P>

<A NAME="T5"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<STRONG>View this table:</STRONG><BR>
<NOBR><A HREF="/cgi/content/full/351/13/1333/T5">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/351/13/1333/T5"
    onClick="startTarget('T5', 731, 723); this.href='/cgi/content-nw/full/351/13/1333/T5'"
 	onMouseOver="window.status='View table in a separate window'; return true"
 	TARGET="T5">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Table 5.</B> Autoimmune Polyendocrine Syndromes.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


<STRONG>Pernicious Anemia</STRONG><P>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="arial, helvetica">Pathophysiological Features</FONT><P>

Dietary vitamin B<SUB>12</SUB> binds to intrinsic factor, which is produced<SUP> </SUP>by cells in the gastric fundus and body, after it dissociates<SUP> </SUP>from protein carriers in the acidic environment of the stomach.<SUP> </SUP>It then travels through the gut to the terminal ileum, where<SUP> </SUP>it is absorbed through a receptor-mediated process.<A HREF="#R4"><SUP>4</SUP></A> <A NAME="5">Deficiency<SUP> </SUP>can be caused by a variety of circumstances: dietary insufficiency<SUP> </SUP>(which is rare), food cobalamin deficiency (i.e., an inability<SUP> </SUP>to split cobalamin from food), achlorhydria (which may be caused<SUP> </SUP>by aging, drugs that inhibit gastric acid secretion, or surgery),<SUP> </SUP>loss of ileal receptors (which may be caused by resection of<SUP> </SUP>the terminal ileum or inflammatory bowel disease), biologic<SUP> </SUP>competition (from <I>Diphyllobothrium latum</I> [the fish tapeworm]<SUP> </SUP>or bacterial overgrowth syndromes), rare congenital syndromes<SUP> </SUP>(such as transcobalamin II deficiency), and lack of production<SUP> </SUP>of intrinsic factor in the stomach because of pernicious anemia,<SUP> </SUP>a process that reflects autoimmune destruction of the gastric<SUP> </SUP>parietal and zymogenic cells.</A><SUP> </SUP><P>

Vitamin B<SUB>12</SUB> is required for two key sets of reactions (<A HREF="#F1">Figure 1</A>).<SUP> </SUP>In nucleic acid metabolism, it is involved in the folate<SUP> </SUP>cycle, and it serves as a methyl group acceptor in the conversion<SUP> </SUP>of methyltetrahydrofolate to tetrahydrofolate, which then goes<SUP> </SUP>on to participate in purine synthesis. In this process, homocysteine<SUP> </SUP>is converted to methionine. The other reaction is the conversion<SUP> </SUP>of propionyl&#150;coenzyme A (CoA) to succinyl-CoA through<SUP> </SUP>the intermediate methylmalonyl-CoA. Although it has been hypothesized<SUP> </SUP>that vitamin B<SUB>12</SUB> deficiency affects the central nervous system<SUP> </SUP>through this mechanism, findings in patients with enzymatic<SUP> </SUP>deficiencies in this pathway do not support this idea. Thus,<SUP> </SUP>the cause of the neurologic manifestations of vitamin B<SUB>12</SUB> deficiency<SUP> </SUP>remains obscure.<A HREF="#R5"><SUP>5</SUP></A><SUP> </SUP><P>

<A NAME="F1"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/351/13/1333/F1"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=128 HEIGHT=68 SRC="/content/vol351/issue13/images/small/14f1.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (5K):<BR>
<NOBR><A HREF="/cgi/content/full/351/13/1333/F1">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/351/13/1333/F1"
    onClick="startTarget('F1', 587, 432); this.href='/cgi/content-nw/full/351/13/1333/F1'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F1">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Figure 1.</B> Metabolic Reactions Involving Vitamin B<SUB>12</SUB>.<P>

Vitamin B<SUB>12</SUB> is involved in both nucleic acid metabolism and lipid metabolism. Its function in nucleic acid metabolism is intimately intertwined with that of folate. Thus, folate supplementation can partially reverse the peripheral effects of vitamin B<SUB>12</SUB> deficiency. CoA denotes coenzyme A.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


Whatever the mechanism, vitamin B<SUB>12</SUB> deficiency can be associated<SUP> </SUP>with permanent neurologic damage, so appropriate diagnosis and<SUP> </SUP>management are critical. Folate supplementation can partially<SUP> </SUP>overcome the anemia and the effect of vitamin B<SUB>12</SUB> deficiency<SUP> </SUP>on the peripheral nerves, but it does not affect the manifestations<SUP> </SUP>in the central nervous system.<A HREF="#R6"><SUP>6</SUP></A><SUP> </SUP><P>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="arial, helvetica">Diagnostic Testing</FONT><P>

Diagnosing vitamin B<SUB>12</SUB> deficiency is straightforward when the<SUP> </SUP>deficiency is profound and there is a hypoproliferative anemia<SUP> </SUP>characterized by marked macrocytosis, hypersegmentation of neutrophils,<SUP> </SUP>pancytopenia, and signs of ineffective erythropoiesis (such<SUP> </SUP>as elevated levels of lactate dehydrogenase and indirect bilirubin)<SUP> </SUP>on laboratory testing. Diagnosing a subtle deficiency, which<SUP> </SUP>appears to be increasingly common, is more challenging. In such<SUP> </SUP>cases, vitamin B<SUB>12</SUB> levels are often in the range of 200 to 300<SUP> </SUP>pg per milliliter (150 to 220 pmol per liter) &#151; low, but<SUP> </SUP>often not below the lower limit of normal. Liver disease and<SUP> </SUP>myeloproliferative diseases can also lead to falsely low-normal<SUP> </SUP>or normal levels of vitamin B<SUB>12</SUB> in patients with pernicious<SUP> </SUP>anemia.<A HREF="#R7"><SUP>7</SUP></A> In such situations, measurement of homocysteine and<SUP> </SUP>methylmalonic acid levels may be useful for documenting true<SUP> </SUP>vitamin B<SUB>12</SUB> deficiency and for distinguishing it from folate<SUP> </SUP>deficiency (<A HREF="#F2">Figure 2</A>). In vitamin B<SUB>12</SUB> deficiency, the levels<SUP> </SUP>of both homocysteine and methylmalonic acid are elevated, whereas<SUP> </SUP>in most cases of folate deficiency only the homocysteine level<SUP> </SUP>is increased. In the absence of renal insufficiency, which can<SUP> </SUP>also elevate the homocysteine level, a methylmalonic acid level<SUP> </SUP>above the normal range is highly suggestive of vitamin B<SUB>12</SUB> deficiency.<SUP> </SUP>The combination of a significant elevation in both methylmalonic<SUP> </SUP>acid and homocysteine virtually confirms the diagnosis.<SUP> </SUP><P>

<A NAME="F2"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/351/13/1333/F2"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=128 HEIGHT=69 SRC="/content/vol351/issue13/images/small/14f2.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (11K):<BR>
<NOBR><A HREF="/cgi/content/full/351/13/1333/F2">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/351/13/1333/F2"
    onClick="startTarget('F2', 590, 437); this.href='/cgi/content-nw/full/351/13/1333/F2'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F2">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Figure 2.</B> Diagnostic Algorithm for Vitamin B<SUB>12</SUB> Deficiency.<P>

Although the diagnosis of vitamin B<SUB>12</SUB> deficiency may be straightforward when the levels are very low or well within the normal range, the levels may often be indeterminate. Serum homocysteine and methylmalonic acid levels can help to define true deficiency. To convert the values for vitamin B<SUB>12</SUB> to picomoles per liter, multiply by 0.7378.<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


<A NAME="6">Although the Schilling test, which involves the sequential administration<SUP> </SUP>of radiolabeled vitamin B<SUB>12</SUB> and intrinsic factor, was once commonly<SUP> </SUP>used in the evaluation of vitamin B<SUB>12</SUB> deficiency, it has fallen<SUP> </SUP>out of favor because of its complexity and the need to administer<SUP> </SUP>radioactive materials.</A> A test for antibodies against parietal<SUP> </SUP>cells may be helpful in some cases, as may a test for antibodies<SUP> </SUP>against intrinsic factor, but the former is relatively nonspecific<SUP> </SUP>and the latter relatively insensitive (though very specific).<SUP> </SUP><P>

In the patient under discussion, the initial diagnostic procedures<SUP> </SUP>should have included a review of the peripheral-blood smear<SUP> </SUP>as well as an evaluation of the vitamin B<SUB>12</SUB> levels. The necessity<SUP> </SUP>of additional diagnostic procedures would then depend on the<SUP> </SUP>findings.<SUP> </SUP><P>

<I>Dr. Nancy Lee Harris</I> (Pathology): Dr. Zarghamee-Gavami, you<SUP> </SUP>followed this patient during and after her initial evaluation.<SUP> </SUP>Would you summarize your thinking before the diagnostic testing?<SUP> </SUP><P>

<I>Dr. Manijeh Zarghamee-Gavami</I> (Medicine): My first concern in<SUP> </SUP>this young woman with numbness of the arms and legs was multiple<SUP> </SUP>sclerosis, and I ordered the MRI study to evaluate this possibility.<SUP> </SUP>Vitamin B<SUB>12</SUB> deficiency was my next consideration. Since her<SUP> </SUP>thyroid disease was well controlled, I did not think it was<SUP> </SUP>the cause of her problems.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Clinical Diagnosis</STRONG></FONT><P>

Pernicious anemia.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Dr. Peter W. Marks's Diagnosis</STRONG></FONT><P>

Pernicious anemia, possibly associated with the autoimmune polyendocrine<SUP> </SUP>syndrome, type IIIB.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Pathological Discussion</STRONG></FONT><P>

<I>Dr. Lawrence R. Zukerberg:</I> The peripheral-blood smear showed<SUP> </SUP>that approximately 10 percent of the mature neutrophils were<SUP> </SUP>hypersegmented, with six or more lobes (<A HREF="#F3">Figure 3</A>). A few hypersegmented<SUP> </SUP>neutrophils may be seen in a variety of disorders, but when<SUP> </SUP>more than 5 percent of the neutrophils are hypersegmented, the<SUP> </SUP>probability of either vitamin B<SUB>12</SUB> deficiency or folate deficiency<SUP> </SUP>is very high. Hypersegmented eosinophils with three lobes were<SUP> </SUP>also present. In addition, there were numerous oval macrocytes<SUP> </SUP>and small and fragmented erythrocytes. The high mean corpuscular<SUP> </SUP>volume, in conjunction with the findings on the peripheral blood<SUP> </SUP>smear, are evidence of megaloblastic anemia. Laboratory studies<SUP> </SUP>showed that the level of vitamin B<SUB>12</SUB> was very low, at 68 pg<SUP> </SUP>per milliliter (50 pmol per liter) (normal, greater than 250<SUP> </SUP>pg per milliliter [184 pmol per liter]). The folate level was<SUP> </SUP>slightly above normal. Therefore, the diagnosis was megaloblastic<SUP> </SUP>anemia due to vitamin B<SUB>12</SUB> deficiency.<SUP> </SUP><P>

<A NAME="F3"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/351/13/1333/F3"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=56 HEIGHT=128 SRC="/content/vol351/issue13/images/small/14f3.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (44K):<BR>
<NOBR><A HREF="/cgi/content/full/351/13/1333/F3">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/351/13/1333/F3"
    onClick="startTarget('F3', 344, 640); this.href='/cgi/content-nw/full/351/13/1333/F3'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F3">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Figure 3.</B> Peripheral-Blood Smear (Wright's Stain).<P>

One hypersegmented neutrophil (Panel A) and a three-lobed, hypersegmented eosinophil (Panel B) from different areas of the smear are shown. Many red cells are enlarged and have an oval shape (macro-ovalocytes).<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


<A NAME="7">To evaluate the cause of the vitamin B<SUB>12</SUB> deficiency, an upper<SUP> </SUP>gastrointestinal endoscopy was performed, and biopsy specimens<SUP> </SUP>were obtained from the duodenum, antrum, and fundus.</A> The duodenum<SUP> </SUP>and antrum were normal, with no evidence of chronic gastritis.<SUP> </SUP>Low-power microscopical examination of the gastric body and<SUP> </SUP>fundus showed extensive atrophy and marked thinning of the mucosa<SUP> </SUP>(<A HREF="#F4">Figure 4A</A>). Closer examination showed severe atrophy, with<SUP> </SUP>complete absence of fundic glands and of chief and parietal<SUP> </SUP>cells. The lamina propria contained a dense lymphocytic infiltrate,<SUP> </SUP>and the mucosa showed intestinal metaplasia with goblet cells<SUP> </SUP>(<A HREF="#F4">Figure 4B</A>).<SUP> </SUP><P>

<A NAME="F4"><!-- null --></A>
<TABLE CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=#E8E8D1><TD><TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=#E8E8D1><TD ALIGN=center VALIGN=top BGCOLOR=ffffff>
<A HREF="/cgi/content/full/351/13/1333/F4"><IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=54 HEIGHT=128 SRC="/content/vol351/issue13/images/small/14f4.gif" ALT=" "></A><BR>

<STRONG>View larger version</STRONG> (57K):<BR>
<NOBR><A HREF="/cgi/content/full/351/13/1333/F4">[in this window]</A><BR>
<A HREF="/cgi/content-nw/full/351/13/1333/F4"
    onClick="startTarget('F4', 335, 640); this.href='/cgi/content-nw/full/351/13/1333/F4'"
 	onMouseOver="window.status='View figure in a separate window'; return true"
 	TARGET="F4">[in a new window]</A><BR>&#160;</NOBR>
</TD><TD ALIGN=left VALIGN=top>
<B>Figure 4.</B> Gastric Biopsy Specimen (Hematoxylin and Eosin).<P>

Low-power magnification of the gastric body (Panel A) shows atrophy with marked mucosal thinning. Higher-power magnification (Panel B and Panel C) shows that the lamina propria is filled with lymphocytes; there are no observable fundic glands or chief or parietal cells, and the surface shows focal intestinal metaplasia with goblet cells (arrows).<P>


</TD></TR></TABLE></TD></TR></TABLE>&nbsp;<BR>


The histologic features of severe chronic atrophic gastritis<SUP> </SUP>limited to the gastric body and fundus are those of autoimmune<SUP> </SUP>gastritis. A test for antibodies to intrinsic factor was positive.<SUP> </SUP>Therefore, the diagnosis was pernicious anemia due to autoimmune<SUP> </SUP>gastritis, with vitamin B<SUB>12</SUB> deficiency.<SUP> </SUP><P>

The pathophysiology of autoimmune gastritis is centered on the<SUP> </SUP>hydrogen&#150;potassium ATPase gastric proton pump.<A HREF="#R2"><SUP>2</SUP></A> This pump<SUP> </SUP>is present only in the parietal cells of the gastric body. The<SUP> </SUP>initial event appears to be a CD4+ T-cell reaction against the<SUP> </SUP>proton pump. The T cells cause parietal-cell injury and result<SUP> </SUP>in exposure of both intrinsic factor and the hydrogen&#150;potassium<SUP> </SUP>ATPase to antigen-presenting cells, activation of the immune<SUP> </SUP>response with secretion of interferon and cytokines, and formation<SUP> </SUP>of antibodies against intrinsic factor and the gastric proton<SUP> </SUP>pump.<SUP> </SUP><P>

Although the immune response is directed only against the components<SUP> </SUP>of the parietal cell, over time there is destruction of both<SUP> </SUP>the chief and parietal cells. There is loss of gastric glands<SUP> </SUP>and infiltration of the lamina propria by lymphocytes and plasma<SUP> </SUP>cells, as in the case under discussion. Intestinal metaplasia<SUP> </SUP>of the surface mucosa eventually develops, leading to an increased<SUP> </SUP>risk of dysplasia and carcinoma. In addition, the lack of acid<SUP> </SUP>leads to increased gastrin production and endocrine-cell hyperplasia<SUP> </SUP>and, in some patients, the development of multiple carcinoid<SUP> </SUP>tumors.<SUP> </SUP><P>

There are additional considerations. First, it has been reported<SUP> </SUP>that in some patients both the gastritis and anemia can be reversed<SUP> </SUP>by treatment with corticosteroids or azathioprine.<A HREF="#R8"><SUP>8</SUP></A><SUP>,</SUP><A HREF="#R9"><SUP>9</SUP></A> In some<SUP> </SUP>patients treated with immunosuppression, the chronic gastritis<SUP> </SUP>disappeared, the gastric mucosa returned to normal, and acid<SUP> </SUP>output increased. Thus, immunosuppression may be one way to<SUP> </SUP>decrease the risk of dysplasia and carcinoma in these patients,<SUP> </SUP>although data showing a reduction in the risk of cancer with<SUP> </SUP>such therapy are lacking. <I>Helicobacter pylori</I> gastritis may<SUP> </SUP>lead to multifocal gastric atrophy, which in some patients leads<SUP> </SUP>to hypoacidity and the development of pernicious anemia. In<SUP> </SUP>a study of 138 patients with vitamin B<SUB>12</SUB> deficiency, <I>H. pylori</I><SUP> </SUP>was detected in 56 percent of the patients, and eradication<SUP> </SUP>of <I>H. pylori</I> improved the anemia and vitamin B<SUB>12</SUB> levels in 40<SUP> </SUP>percent of this subgroup.<A HREF="#R10"><SUP>10</SUP></A> <A NAME="8">Thus, <I>H. pylori</I> appears to be a<SUP> </SUP>causative agent in some cases of vitamin B<SUB>12</SUB> deficiency in adults;<SUP> </SUP>overall, this may be a more common cause than autoimmune gastritis.</A><SUP> </SUP>In this case, there was no evidence of <I>H. pylori</I> infection,<SUP> </SUP>and the absence of the antral inflammation that is typical of<SUP> </SUP>this infection is further evidence against this diagnosis.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Discussion of Management</STRONG></FONT><P>

<I>Dr. Marks:</I> A hundred years ago, pernicious anemia was a major<SUP> </SUP>cause of illness and death. Thanks to the efforts of pioneers<SUP> </SUP>in the field of hematology, a treatment for this disorder was<SUP> </SUP>developed before its pathophysiology was understood.<A HREF="#R11"><SUP>11</SUP></A> George<SUP> </SUP>Minot, William Murphy, and George Whipple demonstrated that<SUP> </SUP>a daily diet that included about 100 to 200 g of beef liver<SUP> </SUP>(which we now know contains about 100 to 200 &#181;g of vitamin<SUP> </SUP>B<SUB>12</SUB>) could rapidly reverse the anemia. In an elegant series<SUP> </SUP>of experiments in which red meat was incubated with gastric<SUP> </SUP>juice for various lengths of time and then was administered<SUP> </SUP>to patients, William Castle demonstrated that gastric juice<SUP> </SUP>appeared to contain an "intrinsic factor" that was required<SUP> </SUP>for absorption of the "extrinsic factor" (vitamin B<SUB>12</SUB>). Vitamin<SUP> </SUP>B<SUB>12</SUB> was isolated almost simultaneously by two independent groups<SUP> </SUP>in 1948, and the nature of its structure was determined by x-ray<SUP> </SUP>crystallography.<SUP> </SUP><P>

Today, the treatment of pernicious anemia involves either parenteral<SUP> </SUP>or oral administration of vitamin B<SUB>12</SUB>. <A NAME="9">Although monthly intramuscular<SUP> </SUP>injection of 100 to 1000 &#181;g of vitamin B<SUB>12</SUB> has long been<SUP> </SUP>a standard treatment for vitamin B<SUB>12</SUB> deficiency, properly administered<SUP> </SUP>oral replacement is equally effective.<A HREF="#R12"><SUP>12</SUP></A> In patients with mild<SUP> </SUP>vitamin B<SUB>12</SUB> deficiency, oral administration of 1 to 2 mg of<SUP> </SUP>vitamin B<SUB>12</SUB> daily can be effective, even as initial therapy.<SUP> </SUP>In practice, it is prudent when treating patients with severe<SUP> </SUP>deficiency to give parenteral vitamin B<SUB>12</SUB> initially.</A> After initial<SUP> </SUP>restoration of normal vitamin B<SUB>12</SUB> levels, a transition to oral<SUP> </SUP>therapy is not unreasonable, although periodic monitoring of<SUP> </SUP>the vitamin B<SUB>12</SUB> levels in such patients may be desirable. Those<SUP> </SUP>who doubt that vitamin B<SUB>12</SUB> can be absorbed by mass action in<SUP> </SUP>the absence of intrinsic factor need only look to the work of<SUP> </SUP>Minot and colleagues: by administering large quantities of liver,<SUP> </SUP>they accomplished the same goal.<SUP> </SUP><P>

A lingering question with respect to pernicious anemia is whether<SUP> </SUP>surveillance for gastric adenocarcinoma, carcinoids, and colonic<SUP> </SUP>polyps is warranted. Although some studies have shown that patients<SUP> </SUP>with pernicious anemia have a severalfold increase in the rate<SUP> </SUP>of gastric and colorectal cancers, others have not. <A NAME="10">At this<SUP> </SUP>time, there are no formal recommendations in the literature<SUP> </SUP>for screening patients with pernicious anemia for gastrointestinal<SUP> </SUP>cancers, although periodic screening of younger persons may<SUP> </SUP>be reasonable.</A><SUP> </SUP><P>

This patient could well have an autoimmune polyendocrine syndrome,<SUP> </SUP>probably type IIIB. Autoimmune polyendocrine syndrome type IIIB<SUP> </SUP>is associated with risks of other disorders, including hypogonadism,<SUP> </SUP>myasthenia gravis, rheumatoid arthritis, and sarcoidosis. The<SUP> </SUP>patient currently has no evidence of these disorders, but her<SUP> </SUP>increased risk for them should be kept in mind as she is followed.<SUP> </SUP><P>

<I>Dr. Deborah J. Wexler</I> (Medicine): What is the prognosis for<SUP> </SUP>the recovery of neurologic function?<SUP> </SUP><P>

<I>Dr. Marks:</I> <A NAME="11">Unfortunately, about 50 percent of patients are left<SUP> </SUP>with at least a mild neurologic deficit after the vitamin B<SUB>12</SUB><SUP> </SUP>deficiency is corrected.</A> Such residual deficits are more common<SUP> </SUP>in patients with long-standing or severe neurologic symptoms<SUP> </SUP>before therapy than in those with symptoms of recent onset or<SUP> </SUP>those with mild symptoms.<SUP> </SUP><P>

<I>Dr. Lloyd Axelrod</I> (Endocrinology): Could you comment on the<SUP> </SUP>risk of hypokalemia in patients with pernicious anemia who are<SUP> </SUP>treated with vitamin B<SUB>12</SUB>? When is potassium replacement indicated?<SUP> </SUP><P>

<I>Dr. Marks:</I> <A NAME="12">Parenteral vitamin B<SUB>12</SUB> replacement can result in<SUP> </SUP>a dramatic proliferation of bone marrow cells, which take up<SUP> </SUP>potassium, and patients can become hypokalemic very quickly.</A><SUP> </SUP>In a person whose vitamin B<SUB>12</SUB> deficiency is severe, I would<SUP> </SUP>monitor potassium levels and provide replacement therapy as<SUP> </SUP>necessary. Sudden death may occur in patients after treatment<SUP> </SUP>for vitamin B<SUB>12</SUB> deficiency is initiated; in addition to hypokalemia,<SUP> </SUP>volume overload may lead to death. When one sees a patient with<SUP> </SUP>severe vitamin B<SUB>12</SUB> deficiency and a hematocrit of 12 to 15 percent,<SUP> </SUP>one may be tempted to transfuse immediately to raise the hematocrit<SUP> </SUP>to a normal level. <A NAME="13">However, most of these patients have arrived<SUP> </SUP>at a low hematocrit over the course of years and tolerate it<SUP> </SUP>well; a transfusion volume sufficient to raise the hematocrit<SUP> </SUP>to a normal level can cause volume overload and cardiac complications.</A><SUP> </SUP><P>

<I>Dr. Zarghamee-Gavami:</I> In the case under discussion, we gave<SUP> </SUP>the patient 1 mg of parenteral vitamin B<SUB>12</SUB> daily for one week,<SUP> </SUP>followed by weekly injections for two months and monthly injections<SUP> </SUP>thereafter. The response was dramatic. Within 7 to 10 days,<SUP> </SUP>she was completely free of symptoms and had no neurologic deficits.<SUP> </SUP>I last saw her six months after the diagnosis was made, and<SUP> </SUP>she had completely recovered. She subsequently moved away from<SUP> </SUP>Massachusetts.<SUP> </SUP><P>

<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Anatomical Diagnosis</STRONG></FONT><P>

Pernicious anemia with autoimmune gastritis and vitamin B<SUB>12</SUB><SUP> </SUP>deficiency.<SUP> </SUP><P>

<SUP> </SUP><P>

<SUP> </SUP><P>


<FONT SIZE=-1>Dr. Marks reports that he is now a senior clinical research<SUP> </SUP>physician at Novartis.<SUP> </SUP><P>

</FONT>
<FONT SIZE=-1></FONT>
<BR><FONT SIZE=+1 FACE="arial, helvetica"><STRONG>Source Information</STRONG></FONT><P><FONT SIZE=-1>
From the Department of Medicine, Division of Hematology, Brigham and Women's Hospital (P.W.M.); the Departments of Medicine (P.W.M.) and Pathology (L.R.Z.), Harvard Medical School; and the Department of Pathology, Massachusetts General Hospital (L.R.Z.) &#151; all in Boston.
</FONT><P>


<FONT SIZE=+1 FACE="arial, helvetica"><STRONG>References</STRONG></FONT><P>

<OL COMPACT>
<A NAME="R1"><!-- null --></A>
<LI VALUE=1>  Pal B. Paresthesia. BMJ 2002;324:1501-1501.<!-- HIGHWIRE ID="351:13:1333:1" --><A HREF="/cgi/ijlink?linkType=FULL&journalCode=bmj&resid=324/7352/1501" ><nobr>[Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><A NAME="R2"><!-- null --></A>
<LI VALUE=2>  Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997;337:1441-1448.<!-- HIGHWIRE ID="351:13:1333:2" --><A HREF="/cgi/ijlink?linkType=FULL&journalCode=nejm&resid=337/20/1441" ><nobr>[Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><A NAME="R3"><!-- null --></A>
<LI VALUE=3>  Muir A, Maclaren NK. Autoimmune diseases of the adrenal glands, parathyroid glands, gonads, and hypothalamic-pituitary axis. Endocrinol Metab Clin North Am 1991;20:619-644.<!-- HIGHWIRE ID="351:13:1333:3" --><A HREF="/cgi/external_ref?access_num=A1991HK72700010&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=1935921&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R4"><!-- null --></A>
<LI VALUE=4>  Pruthi RK, Tefferi A. Pernicious anemia revisited. Mayo Clin Proc 1994;69:144-150.<!-- HIGHWIRE ID="351:13:1333:4" --><A HREF="/cgi/external_ref?access_num=A1994MV03700009&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=8309266&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R5"><!-- null --></A>
<LI VALUE=5>  Carmel R, Melnyk S, James SJ. Cobalamin deficiency with and without neurologic abnormalities: differences in homocysteine and methionine metabolism. Blood 2003;101:3302-3308.<!-- HIGHWIRE ID="351:13:1333:5" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=bloodjournal&resid=101/8/3302" ><nobr>[Abstract/Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><A NAME="R6"><!-- null --></A>
<LI VALUE=6>  Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996;156:1097-1100.<!-- HIGHWIRE ID="351:13:1333:6" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=archinte&resid=156/10/1097" >[Abstract]</A><!-- /HIGHWIRE --><A NAME="R7"><!-- null --></A>
<LI VALUE=7>  Snow CF. Laboratory diagnosis of vitamin B<SUB>12</SUB> and folate deficiency: a guide for the primary care physician. Arch Intern Med 1999;159:1289-1298.<!-- HIGHWIRE ID="351:13:1333:7" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=archinte&resid=159/12/1289" ><nobr>[Abstract/Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><A NAME="R8"><!-- null --></A>
<LI VALUE=8>  Wall AJ, Whittingham S, Mackay IR, Ungar B. Prednisolone and gastric atrophy. Clin Exp Immunol 1968;3:359-366.<!-- HIGHWIRE ID="351:13:1333:8" --><A HREF="/cgi/external_ref?access_num=4871897&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R9"><!-- null --></A>
<LI VALUE=9>  Jorge AD, Sanchez D. The effect of azathioprine on gastric mucosal histology and acid secretion in chronic gastritis. Gut 1973;14:104-106.<!-- HIGHWIRE ID="351:13:1333:9" --><A HREF="/cgi/external_ref?access_num=A1973P333800005&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=4696531&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R10"><!-- null --></A>
<LI VALUE=10>  Kaptan K, Beyan C, Ural AU, et al. Helicobacter pylori -- is it a novel causative agent in vitamin B12 deficiency? Arch Intern Med 2000;160:1349-1353.<!-- HIGHWIRE ID="351:13:1333:10" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=archinte&resid=160/9/1349" ><nobr>[Abstract/Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --><A NAME="R11"><!-- null --></A>
<LI VALUE=11>  Chanarin I. A history of pernicious anemia. Br J Haematol 2000;111:407-415.<!-- HIGHWIRE ID="351:13:1333:11" --><A HREF="/cgi/external_ref?access_num=10.1046/j.1365-2141.2000.02238.x&link_type=DOI" >[CrossRef]</A><A HREF="/cgi/external_ref?access_num=000165827300005&link_type=ISI" onClick="ISIwin('ISI')" TARGET="ISI">[ISI]</A><A HREF="/cgi/external_ref?access_num=11122079&link_type=MED" onClick="ISIwin('ISI')" TARGET="ISI">[Medline]</A><!-- /HIGHWIRE --><A NAME="R12"><!-- null --></A>
<LI VALUE=12>  Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92:1191-1198.<!-- HIGHWIRE ID="351:13:1333:12" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=bloodjournal&resid=92/4/1191" ><nobr>[Abstract/Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE --></OL>






		
        
        
	
	
	
	
	






 




<BR CLEAR=ALL>


	
	 
		  
			 
			
			                    



 
	 

<table border="0" cellpadding="0" cellspacing="0" width="200" ALIGN="RIGHT">
<tr>
<td width="20">&nbsp;</td>
<TD BGCOLOR="336699">

<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1">

	<TR VALIGN="top">
		<td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
			<img src="/icons/v3_this_article.gif" alt="This Article" width="73" height="8" BORDER="0"><BR>
			<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
	</tr><tr>
		<td> 
                <table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
		<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
		
		
		
		

		
		 

		
		<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b>
			
			
			
				
						
						<A class="contentboxLinks" HREF="/cgi/reprint/351/13/1333.pdf">PDF</A></b></font></td></tr>
		
		<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/ac_external_ref?link_type=pda_mms&doi=10.1056%2FNEJMcpc040921">PDA Full Text</A></b></font></td></tr>
		
		
			<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="http://cme.nejm.org/cgi/cme/nejmcme_course;NJ200409233511334">CME Exam</A></b></font></td></tr>
		
		

		

		

		 
		
		



	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	</table>
        </td>
        </tr>







        <tr>
        <td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
	<img src="/icons/v3_commentary.gif" alt="Commentary" width="80" height="8" align="absmiddle"><BR>
	<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
        </tr>
        <tr>
        <td>
        <table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
        
	
	
	
	
	
	
		<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="#related_letters">Letters</A></b></font></td></tr>
	
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	</table>
	</td>
	</tr>



	<tr> 
	<td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
	<img src="/icons/v3_tools_service.gif" alt="Tools and Services" width="103" height="9" align="absmiddle"><BR>
	<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
	</tr>
	<tr> 
	<td> 
	<table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	
		
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/folders?action=addtofolder&wherefrom=JOURNALS&wrapped_id=nejm;351/13/1333">Add to Personal Archive</A></b></font></td></tr>
	
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/citmgr?gca=nejm;351/13/1333">Add to Citation Manager</A></b></font></td></tr>
	
	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/mailafriend?url=http://content.nejm.org/cgi/content/short/351/13/1333&title=Case+30-2004+-+A+37-Year-Old+Woman+with+Paresthesias+of+the+Arms+and+Legs"><b>Notify a Friend</b></a></b></font></td></tr>

	
        <tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=nejm;351/13/1333&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F351%2F13%2F1333">E-mail When Cited</A></b></font></td></tr>

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/ac_external_ref?link_type=letters_mms&doi=10.1056%2FNEJMcpc040921">E-mail When Letters Appear</A></b></font></td></tr>
	
	
	
	

	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
	</table>
        </td>
        </tr>



        <tr>
        <td width="200" bgcolor="#E8E8D1" ALIGN="CENTER"><img src="/icons/home/spacer.gif" width="1" height="6" alt=""><BR>
	<img src="/icons/v3_more_information.gif" alt="More Information" width="116" height="8" align="absmiddle"><BR>
	<img src="/icons/home/spacer.gif" width="1" height="6" alt=""></td>
        </tr>
        <tr>
        <td>
        <table cellpadding="2" cellspacing="0" width="100%" BORDER="0" BGCOLOR="#FFFFFF">
	<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
        

	

	

	

	

	

	

	

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/search?qbe=nejm;351/13/1333&journalcode=nejm&minscore=5000">Find Similar Articles</A></b></font></td></tr>

	
	<tr valign="top"><td WIDTH=15 valign="top" ALIGN="CENTER"><img src="/icons/v3_arrow_right.gif" alt="-" border="0" width="9" height="8" vspace="3"></td><td valign="middle"><font face="arial, helvetica, sans-serif" size=-1><b><A class="contentboxLinks" HREF="/cgi/external_ref?access_num=15385661&link_type=PUBMED" onClick="ISIwin('ISI')" TARGET="ISI">PubMed Citation</A></b></font></td></tr>

<tr valign="top"><td colspan="2"><img src="/icons/home/spacer.gif" alt="" height="1" border="0" hspace="3"></td></tr>
</table>
</td>
</tr>

        
        
</table>
</table>	 <!-- end of outer content box1 -->
</TABLE>	 <!-- end of outer content box2 -->



			
			
					
	




<A NAME="related_letters"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>Related Letters:</STRONG></FONT>
<P>
	
		  	
	<FONT FACE="arial,helvetica">
	<STRONG><a href="/cgi/content/short/352/4/419" style="color: #000000;text-decoration: none;">
	Case 30-2004: A Woman with Paresthesias</a></STRONG><BR>
	Davies S. V., Marks P. W.<BR>
    <NOBR>
	
	 <A HREF="/cgi/content/extract/352/4/419">Extract</A> |
	 <A HREF="/cgi/content/full/352/4/419">Full Text</A> |
	 <A HREF="/cgi/reprint/352/4/419.pdf">PDF</A> 
	
	&nbsp;</NOBR><BR>			
	N Engl J Med 2005;
	 
		352:419-420, Jan 27, 2005. 
	
	<B>Correspondence</B>
	</FONT>

		<P>
	





<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>
	<UL>
	
	<LI>Bain, B. J.
		(2005).  Diagnosis from the Blood Smear.  <EM>N Engl J Med</EM> 

		
			353: 498-507
		
		<NOBR>
			
			<A HREF="http://content.nejm.org/cgi/content/full/353/5/498">[Full Text]</A>
		&nbsp;</NOBR>
	
	<LI>Davies, S. V., Marks, P. W.
		(2005).  Case 30-2004: A Woman with Paresthesias.  <EM>N Engl J Med</EM> 

		
			352: 419-420
		
		<NOBR>
			
			<A HREF="http://content.nejm.org/cgi/content/full/352/4/419">[Full Text]</A>
		&nbsp;</NOBR>
	
	</UL>


<BR CLEAR=ALL>


	

	<table width="100%" border="0" cellspacing="0" cellpadding="0" align="center">
	<tr> 
	<td align="center"><hr size="1" color="#000000" noshade>
	<p><font face="arial, helvetica, sans-serif">
	<a href="/" class="footerLinks">HOME</a> &nbsp;&nbsp;|&nbsp;&nbsp;
	<a href="/search.dtl" class="footerLinks">SEARCH</a> &nbsp;&nbsp;|&nbsp;&nbsp;
	<a href="/current.shtml" class="footerLinks">CURRENT ISSUE</a> &nbsp;&nbsp;|&nbsp;&nbsp;
	<a href="/contents-by-date.0.shtml" class="footerLinks">PAST ISSUES</a> &nbsp;&nbsp;|&nbsp;&nbsp;
	<a href="/collections/" class="footerLinks">COLLECTIONS</a> &nbsp;&nbsp;|&nbsp;&nbsp;
	<a href="/help/" class="footerLinks">HELP</a>
</font></p>
	<p><font face="arial, helvetica, sans-serif">Comments and questions?
	Please <a href="http://www.nejm.org/custserv/feedback.asp">contact us</a>.</font></p>
	<p><font face="Times New Roman">
	<font face="Times New Roman"><b>The New England Journal of Medicine is owned, published, and <a href="http://www.nejm.org/aboutnejm/copyright.asp">copyrighted</a> &copy; 2005 <A HREF ="http://www.massmed.org/">Massachusetts Medical Society</A>.
	All rights reserved.</b></font>
</font></p></td>
	</tr>
	</table>



        <SCRIPT LANGUAGE="JavaScript">
        <!--
        function startTarget(windowname,wid,hei) {
        
        var dotpos = windowname.indexOf(".");
        if (dotpos > -1)
        {
        var tempwn = windowname.substring(0,dotpos) +
                windowname.substring(dotpos + 1, windowname.length);
        windowname = tempwn;
        }
        var sizestring = 'width=' + wid + ',height=' + hei;
        window.open('',windowname,'scrollbars,resizable,menubar,' + sizestring + '\'');
        }
        // -->
        </SCRIPT>

<script language="JavaScript">
<!--
if ( top != self )
{
     top.location.href = unescape(window.location.pathname);
}

function ISIwin(windowname) {
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1) {
		var tempwn = windowname.substring(0,dotpos) +
        windowname.substring(dotpos + 1, windowname.length);
		windowname = tempwn;
	}
	newwin = window.open('', windowname, 'width=700,height=400,left=30,top=30,screenX=30,screenY=30,resizable,scrollbars,toolbar,location,status,menubar');
	setTimeout('newwin.focus();',250);
}

//-->
</script>

</BODY>
</HTML>

